Seres Therapeutics Inc (MCRB) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.88
• Market Cap: $80.42M
• P/E Ratio: 10.10
• EPS: $0.88
• 52-Week High: $29.98
• 52-Week Low: $6.53

Market Sentiment

Seres Therapeutics Inc currently has a Bullish sentiment score of 0.26.

About Seres Therapeutics Inc

Seres Therapeutics, Inc. (MCRB) is a pioneering microbiome therapeutic platform company based in Cambridge, Massachusetts, focused on developing innovative bacterial consortia to address a variety of diseases, including Clostridioides difficile infections and inflammatory bowel disease. The company leverages its extensive expertise in microbiome science to create transformative therapies designed to restore microbiome balance and improve patient outcomes. With a robust pipeline and a strong c...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Seres Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MCRB pay dividends?

Seres Therapeutics Inc (MCRB) does not currently pay a regular dividend.

What is MCRB's P/E ratio?

Seres Therapeutics Inc has a price-to-earnings (P/E) ratio of 10.10.

What is MCRB's market cap?

Seres Therapeutics Inc (MCRB) has a market capitalization of $80.42M with a current stock price of $8.88.